GlassScriptPhysician profile
Gary S Friedlander
NPI 1083716195
$10,401.21
in general payments reported to CMS, 2019-2025
45 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $849 · 2021: $1,150 · 2022: $2,295 · 2023: $1,744 · 2024: $1,516 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,904 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,903.96 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,714.01 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $839.50 | 2019-2025 | |
| Astellas Pharma US INC | $824.21 | 2019-2025 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $663.71 | 2019-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $537.02 | 2021-2025 | Pylarify |
| Boston Scientific Corporation | $489.63 | 2019-2025 | Spaceoar Vue System - 10ml, Greenlight Xps, Ams 800 Artificial Urinary Sphincter |
| Sumitomo Pharma America, INC. | $468.87 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $414.87 | 2019-2024 | Xiaflex, Edex, Aveed |
| Neotract INC. | $376.75 | 2020 | |
| Urogen Pharma, INC. | $351.35 | 2021-2025 | Jelmyto |
| Antares Pharma, INC. | $307.95 | 2019-2025 | Xyosted |
| Dendreon Pharmaceuticals LLC | $268.46 | 2019-2023 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $253.13 | 2019-2025 | |
| Allergan, INC. | $247.19 | 2019-2022 | |
| Urovant Sciences INC | $214.16 | 2021-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $198.36 | 2019-2025 | Porges Coloplast, Speedicath |
| Axonics, INC. | $187.75 | 2024 | Axonics |
| Myriad Genetic Laboratories, INC. | $176.65 | 2021-2024 | Prolaris |
| Endo USA, INC. | $169.81 | 2024-2025 | Xiaflex, Aveed, Edex |
| Ferring Pharmaceuticals INC. | $169.32 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $167.92 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $150.01 | 2021-2025 | Lynparza, Imfinzi |
| Amgen INC. | $119.60 | 2019-2022 | |
| Medtronic, INC. | $119.12 | 2023-2024 | Interstim |
| Merck Sharp & Dohme LLC | $117.37 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Tolmar Pharmaceuticals, INC. | $110.69 | 2019-2022 | |
| Tolmar, INC. | $101.36 | 2023-2025 | Eligard, Jatenzo |
| Accord Healthcare, INC. | $85.51 | 2023-2024 | |
| Acerus Pharmaceuticals Corporation | $85.35 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $53.62 | 2025 | Erleada |
| Halozyme INC | $49.92 | 2023 | |
| Blue Earth Diagnostics | $46.44 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $45.22 | 2022 | |
| 180 Medical, INC. | $44.26 | 2022-2025 | |
| Tempus Ai, INC | $29.48 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $28.40 | 2019 | |
| Clarus Therapeutics INC. | $25.85 | 2021 | |
| Lantheus Medical Imaging, INC. | $25.83 | 2024 | |
| Verity Pharmaceuticals INC. | $21.77 | 2025 | Trelstar |
| Abc Home Medical Supply, INC. | $19.24 | 2024 | |
| Genzyme Corporation | $19.04 | 2023 | |
| Telix Pharmaceuticals | $16.78 | 2024 | Illuccix |
| Olympus America INC. | $16.38 | 2020 | |
| Dentsply Ih Ab | $14.92 | 2024 | Lofric |
| Vertex Pharmaceuticals Incorporated | $14.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Friedlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.